Catalyst Pharmaceuticals, Inc. will release its second quarter 2025 financial results on August 6, 2025, and host a conference call and webcast on August 7, 2025, at 8:30 AM ET to discuss the results and provide a business update. The conference call details are available on the company’s website. Catalyst Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for rare diseases. The company prioritizes patient care and accessibility, with a strong U.S. presence and plans for global expansion. Forward-looking statements in this press release highlight potential risks and uncertainties affecting Catalyst’s future results.

Read more at GlobeNewswire: Catalyst Pharmaceuticals to Report Second Quarter 2025